Scarica l'app Stockscreener
15.82
4.08%
0.62
Pre-mercato:
15.32
-0.50
-3.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$15.20
Aprire:
$15.26
Volume 24 ore:
1.05M
Relative Volume:
0.87
Capitalizzazione di mercato:
$796.38M
Reddito:
-
Utile/perdita netta:
$-156.39M
Rapporto P/E:
-4.2873
EPS:
-3.69
Flusso di cassa netto:
$-123.06M
1 W Prestazione:
+17.53%
1M Prestazione:
+21.23%
6M Prestazione:
+36.26%
1 anno Prestazione:
+22.92%
Intervallo 1D:
$15.04
$15.85
Intervallo di 1 settimana:
$13.47
$15.85
Portata 52W:
$7.30
$16.32
Kalvista Pharmaceuticals Inc Stock (KALV) Company Profile
Nome
Kalvista Pharmaceuticals Inc
Settore
Industria
Telefono
(857) 999-0075
Indirizzo
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Confronta KALV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KALV
Kalvista Pharmaceuticals Inc
|
15.82 | 765.17M | 0 | -156.39M | -123.06M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Kalvista Pharmaceuticals Inc Stock (KALV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-31 | Iniziato | JMP Securities | Mkt Outperform |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-12-18 | Iniziato | BofA Securities | Buy |
| 2020-06-15 | Iniziato | H.C. Wainwright | Buy |
| 2019-07-29 | Iniziato | SVB Leerink | Outperform |
| 2019-03-20 | Iniziato | Needham | Buy |
| 2018-10-30 | Iniziato | Jefferies | Buy |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-08-31 | Iniziato | BTIG Research | Buy |
Mostra tutto
Kalvista Pharmaceuticals Inc Borsa (KALV) Ultime notizie
What analysts say about KalVista Pharmaceuticals Inc. stockJuly 2025 Rallies & Daily Profit Maximizing Tips - beatles.ru
Short interest data insights for KalVista Pharmaceuticals Inc.2025 Top Gainers & Daily Volume Surge Signals - Newser
Is KalVista Pharmaceuticals Inc. stock a smart retirement pickWeekly Stock Recap & Reliable Volume Spike Alerts - خودرو بانک
Aug Rallies: What is KalVista Pharmaceuticals Inc. s 5 year growth outlook2025 Big Picture & Capital Protection Trade Alerts - خودرو بانک
Can KalVista Pharmaceuticals Inc. deliver consistent dividendsQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - خودرو بانک
Can technical indicators confirm KalVista Pharmaceuticals Inc.’s reversalChart Signals & Safe Entry Point Alerts - Newser
KalVista Pharmaceuticals Inc. stock volume spike explainedGap Down & Real-Time Stock Entry Alerts - Newser
Does KalVista Pharmaceuticals (NASDAQ:KALV) Have A Healthy Balance Sheet? - 富途牛牛
Is KalVista Pharmaceuticals Inc. building a consolidation base2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
What MACD and RSI say about KalVista Pharmaceuticals Inc.Analyst Downgrade & High Conviction Buy Zone Alerts - Newser
Is KalVista Pharmaceuticals (NASDAQ:KALV) A Risky Investment? - simplywall.st
Can volume confirm reversal in KalVista Pharmaceuticals Inc.2025 Market Trends & Low Drawdown Trading Techniques - Newser
Combining machine learning predictions for KalVista Pharmaceuticals Inc.Trend Reversal & Daily Volume Surge Signals - Newser
Evaluating KalVista Pharmaceuticals Inc. with trendline analysisMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Can KalVista Pharmaceuticals Inc. maintain sales growthEarnings Growth Summary & Stepwise Entry and Exit Trade Signals - خودرو بانک
KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025 - Business Wire
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KalVista Q1 Earnings On DeckWill Sebetralstat's EU Nod Be The Catalyst It Needs? - RTTNews
Institutional scanner results for KalVista Pharmaceuticals Inc.Wall Street Watch & High Accuracy Swing Entry Alerts - Newser
Applying Elliott Wave Theory to KalVista Pharmaceuticals Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - Newser
What’s the recovery path for long term holders of KalVista Pharmaceuticals Inc.2025 Volatility Report & Free Weekly Watchlist of Top Performers - Newser
What is KalVista Pharmaceuticals Inc. s debt to equity ratioDip Buying & Safe Entry Point Identification - خودرو بانک
Price action breakdown for KalVista Pharmaceuticals Inc.Jobs Report & Verified Momentum Stock Ideas - Newser
How high can KalVista Pharmaceuticals Inc. stock goMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser
Price momentum metrics for KalVista Pharmaceuticals Inc. explainedSwing Trade & Weekly Top Performers Watchlists - Newser
Chart based exit strategy for KalVista Pharmaceuticals Inc.2025 Top Decliners & AI Driven Stock Reports - Newser
How institutional ownership impacts KalVista Pharmaceuticals Inc. stock2025 Top Gainers & Consistent Profit Alerts - Newser
KALVISTA PHARMACEUTICALS Earnings Preview: Recent $KALV Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
KalVista Pharmaceuticals Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - 강소기업뉴스
Analyzing recovery setups for KalVista Pharmaceuticals Inc. investorsTrade Volume Report & Technical Entry and Exit Tips - Newser
Real time social sentiment graph for AFRIWJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Sentiment analysis tools applied to KalVista Pharmaceuticals Inc.July 2025 Volume & Fast Gaining Stock Reports - Newser
Heatmap Data Shows High Activity in KalVista Pharmaceuticals Inc. Sector2025 Pullback Review & Growth Oriented Trading Recommendations - beatles.ru
How to build a dashboard for KalVista Pharmaceuticals Inc. stockWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Kalvista Pharmaceuticals Inc Azioni (KALV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):